Lewis from CRL were used as the background strain. This strain was made by pronuclear injection into Lewis embryos. The embryos were coinjected with DNA fragments containing the HLA-B*0702 human gene and the human beta-2-microglobulin gene. Founder 120-4 was selected and carrier animals from this founder were mated and this strain was bred to homozygosity.
Genetic Status:
Homozygous
Coat Color:
Albino
Last Known Status:
Cryopreserved Embryo; Cryopreserved Sperm (as of 2020-07-08)
These animals are normal and healthy. This strain serves as the control strain for the HLA B27 transgenic rats which develop autoimmune arthritis, the HLA B7 transgene is not associated with any phenotype. Hemizygous animals have the highest copy number of the HLA-B7 locus (26) whereas the copy number of human B2M is low (5).
In human the B27 gene product is responsible for spondyloarthropathies suggesting this molecule may contribute to B27-associated disease susceptibility.